טוען...
The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats
BACKGROUND: Given the problems associated with the escalation in methamphetamine (METH) use, the identification of more effective treatment strategies is essential. Group II metabotropic glutamate receptors (mGluRs) have been suggested to be a novel therapeutic target for psychostimulant addiction....
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804156/ https://ncbi.nlm.nih.gov/pubmed/23953655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2013.07.024 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|